Lakewood-Amedex Biotherapeutics, Inc. (LABT)

NASDAQ: LABT · Real-Time Price · USD

0.7822

-0.0098 (-1.24%)

At close: Oct 9, 2026, 4:00 PM EDT

0.7704

-0.0118 (-1.51%)

After-hours: Oct 9, 2026, 7:49 PM EDT

LABT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	0.02	-0.84	0.67	0.13
Net Debt / Equity Ratio	-1.03	-0.72	-1.00	-1.27
Net Debt / EBITDA Ratio	0.62	-0.38	0.10	0.67
Net Debt / FCF Ratio	1.29	-0.73	0.07	0.85
Quick Ratio	7.29	0.10	1.36	3.10
Current Ratio	7.70	0.13	1.55	3.14
Return on Equity (ROE)	-402.83%	-	-195.47%	-
Return on Assets (ROA)	-139.40%	-303.80%	-63.20%	-
Return on Capital Employed (ROCE)	-167.80%	196.10%	-706.50%	-178.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Oct '26 Oct 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Buyback Yield / Dilution	-27.02%	-0.78%	-1.44%	-

SEC Filings: 10-K · 10-Q